Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

103980-44-5

Ceftiofur HCl

103980-44-5
83881-52-1

Cetirizin Dihydrochloride

83881-52-1
56238-63-2

Cefuroxime Sodium Salt

56238-63-2
62893-19-0

Cefoperazone

62893-19-0
5575-21-3

Cefalonium Hydrate

5575-21-3
1188264-72-3

Citalopram Desmethyl HBr

1188264-72-3
50-18-0

Cyclophosphamide

50-18-0
61177-45-5

Potassium clavulanate

61177-45-5
15686-71-2

Cephalexin

15686-71-2
123171-59-5

Cefepime 2HCl H2O

123171-59-5
50-63-5

Chloroquine Diphosphate

50-63-5
NA

Colistin A Sulfate H20

NA
1338055-88-1

Colistin B Sulfate Salt

1338055-88-1
68-39-3

rac Cycloserine

68-39-3
137-08-6

Calcium-D pantothenate Vitamine B5

137-08-6
52-89-1

L-Cysteine HCl

52-89-1
41575-94-4

Carboplatin

41575-94-4
28657-80-9

Cinoxacin

28657-80-9
1264-72-8

Colistin sulfate salt

1264-72-8
71-30-7

Cytosine

71-30-7